Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies.

Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies.
Related ArticlesHyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies. Front Nutr. 2019;6:49 Authors: Tinelli C, Di Pino A, Ficulle E, Marcelli S, Feligioni M Abstract Hyperhomocysteinemia is recognized as a risk factor for several diseases, including cardiovascular and neurological conditions. Homocysteine (HCys) is a key metabolite involved in the biosynthesis and metabolism of methionine (Met), which ... read more
Source: PubMedPublished on 2019-05-10